Protea Foundation
Review Articles of Incorporation and Bylaws
Expand access to new psychedelic-assisted therapies for women suffering from childhood trauma.
Posted April 24, 2024
Background & Context
The founder, Cristina Pearse, was a participant in the MAPS- supported FDA trial that concluded in 2023. Cristina is a early childhood trauma survivor. The outcome of the trial was groundbreakingly effective.
Cristina has testified to the FDA, and is receiving significant media coverage from PBS, CBS, Bloomberg, and many other media outlets. The Foundation was created to educate the public, bring awareness and tools to children facing trauma, and train facilitators on available psychedelic and empathogenic treatments.
Immediate Problem
Ensure the Foundation has the right legal "foundation". Ensure the foundation and its members are not facing legal issues as we proceed.
Work & Deliverables
Review articles of incorporation and bylaws. Ensure volunteers and management are protected from liability. Position our status in most favorable IRS position for donors to maximize benefit. We have documents already submitted to Colorado and the IRS but wish to make them stronger through review.
Preparation Phase
- Review articles of incorporation, offer legal advice to ensure success of foundation
Collaboration Phase
Wrap Up
- Legal support to provide itemized list of suggested changes to documents, and other suggestions
.jpg){kind=small}
Protea Foundation
The purpose of this nonprofit corporation is to expand access to psychedelic treatment options for women suffering from childhood trauma. This includes funding direct treatment as well as education and outreach for resilience and prevention.
Protea Foundation
The purpose of this nonprofit corporation is to expand access to psychedelic treatment options for women suffering from childhood trauma. This includes funding direct treatment as well as education and outreach for resilience and prevention.